Poland · Delayed Price · Currency is PLN Medinice Statistics
Total Valuation
Medinice has a market cap or net worth of PLN 572.06 million. The enterprise value is 567.88 million.
| Market Cap | 572.06M |
| Enterprise Value | 567.88M |
Important Dates
The next confirmed earnings date is Friday, September 11, 2026.
| Earnings Date | Sep 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Medinice has 9.29 million shares outstanding. The number of shares has increased by 25.19% in one year.
| Current Share Class | 9.29M |
| Shares Outstanding | 9.29M |
| Shares Change (YoY) | +25.19% |
| Shares Change (QoQ) | +0.94% |
| Owned by Insiders (%) | 9.69% |
| Owned by Institutions (%) | 27.99% |
| Float | 7.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 6.79 |
| P/TBV Ratio | 1,932.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.31
| Current Ratio | 2.31 |
| Quick Ratio | 2.28 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -42.26 |
Financial Efficiency
Return on equity (ROE) is -9.75% and return on invested capital (ROIC) is -5.98%.
| Return on Equity (ROE) | -9.75% |
| Return on Assets (ROA) | -5.64% |
| Return on Invested Capital (ROIC) | -5.98% |
| Return on Capital Employed (ROCE) | -8.95% |
| Weighted Average Cost of Capital (WACC) | 10.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -14,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +383.52% in the last 52 weeks. The beta is 1.10, so Medinice's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | +383.52% |
| 50-Day Moving Average | 75.09 |
| 200-Day Moving Average | 53.32 |
| Relative Strength Index (RSI) | 27.17 |
| Average Volume (20 Days) | 31,287 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -295,000 |
| Operating Income | -7.82M |
| Pretax Income | -7.96M |
| Net Income | -7.95M |
| EBITDA | -7.70M |
| EBIT | -7.82M |
| Earnings Per Share (EPS) | -0.90 |
Balance Sheet
The company has 4.18 million in cash and no debt, with a net cash position of 4.18 million or 0.45 per share.
| Cash & Cash Equivalents | 4.18M |
| Total Debt | n/a |
| Net Cash | 4.18M |
| Net Cash Per Share | 0.45 |
| Equity (Book Value) | 84.29M |
| Book Value Per Share | 9.00 |
| Working Capital | 2.54M |
Cash Flow
| Operating Cash Flow | -5.91M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 116,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -5.91M |
| FCF Per Share | -0.64 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Medinice does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.19% |
| Shareholder Yield | -25.19% |
| Earnings Yield | -1.39% |
| FCF Yield | -1.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |